Records containing: Solid Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase I Open-label Dose Escalation Study With Expansion to Assess the Safety and Tolerability of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase Ib Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-12-17A Phase I/II, Multi-center, Open-label Study of BGT226, Administered Orally in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2020-12-10A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
-
CLINICAL_TRIALS study record update · 2020-12-08An Open-label Single Center Study to Characterize the Absorption, Distribution, Metabolism, and Elimination (ADME) of Patupilone (EPO906) After a Single Intravenous Administration of 10 mg/m2 [14C] Patupilone in Patients With Advanced Solid Tumor Malignancies.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-08An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2020-11-13A Phase 1 Study of Topotecan Liposomes Injection (TLI) in Subjects With Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-10-26Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
-
CLINICAL_TRIALS study record update · 2020-09-30A Phase I Trial to Investigate the Tolerability, Safety, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Japanese Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion Part in Asian Subjects With Gastric Cancer
-
CLINICAL_TRIALS study record update · 2020-09-30An Open-label Phase 1b Study of ARQ 092 in Combination With Other Antineoplastic Agents in Subjects With Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-10An Investigator Sponsored Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Doses Followed by Dose Expansion of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Asian Patients With Advanced or Metastatic Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2020-09-10A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1 Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A First-in-Human, Open-label, Phase 1 Dose-Escalation Study of 609A in Subjects With Locally Advanced/Metastatic Solid Tumors in China
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1 Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-09A Phase 1b Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2020-09-03Evaluation Kanitinib Treatment of Recurrent or Metastatic Malignant Solid Tumors Safety, Tolerability and Pharmacokinetic Open, Dose Escalation Phase I Clinical Study
-
CLINICAL_TRIALS study record update · 2020-09-03A First-in-Human, Open-Label, Multicenter, Dose-Escalation Phase I Clinical Study of Single-Agent RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
-
CLINICAL_TRIALS study record update · 2020-08-11A Phase 1 Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-07-30A Phase I Study to Evaluate the Safety,Tolerability and Pharmacokinetics of RC48-ADC for Injection in Subjects With Advanced Malignant Solid Tumors With HER2-positive
-
CLINICAL_TRIALS study record update · 2020-07-16A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-07-14Registry Study for Personalized Cancer Therapy
-
CLINICAL_TRIALS study record update · 2020-07-10A Phase 1, Open-Label, Multiple-Ascending-Dose Study of DS-2248, an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2020-06-22A Phase 1b, Open-Label, Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Patients With Solid Tumors